(Q38799538)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26809239%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

title

BMPR2 gene therapy for PAH acts via Smad and non-Smad signalling (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26809239%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

0 references

Ann M Reynolds

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26809239%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Paul N Reynolds

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26809239%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

publication date

26 January 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26809239%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26809239%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26809239%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26809239%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

page(s)

727-733

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26809239%20AND%20SRC:MED&resulttype=core&format=json

Updated clinical classification of pulmonary hypertension.

6 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12729

Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12729

Cellular and molecular pathobiology of pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12729

Mutations in bone morphogenetic protein type II receptor cause dysregulation of Id gene expression in pulmonary artery smooth muscle cells: implications for familial pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12729

SMAD versus non-SMAD signaling is determined by lateral mobility of bone morphogenetic protein (BMP) receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12729

Smad-dependent and Smad-independent pathways in TGF-beta family signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12729

Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12729

Mutation in the gene for bone morphogenetic protein receptor II as a cause of primary pulmonary hypertension in a large kindred

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12729

Altered bone morphogenetic protein and transforming growth factor-beta signaling in rat models of pulmonary hypertension: potential for activin receptor-like kinase-5 inhibition in prevention and progression of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12729

Combined transductional and transcriptional targeting improves the specificity of transgene expression in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12729

A targetable, injectable adenoviral vector for selective gene delivery to pulmonary endothelium in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12729

Bone morphogenetic protein type 2 receptor gene therapy attenuates hypoxic pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12729

Targeted gene delivery of BMPR2 attenuates pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12729

Downregulation of type II bone morphogenetic protein receptor in hypoxic pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12729

A quantitative method for measuring protein phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12729

Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12729

Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12729

Overexpression of human bone morphogenetic protein receptor 2 does not ameliorate monocrotaline pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12729

Transgene expression up to 7 years in nonhuman primates following hepatic transduction with helper-dependent adenoviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12729

FK506 activates BMPR2, rescues endothelial dysfunction, and reverses pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12729

Investigation of Second Genetic Hits at the BMPR2 Locus as a Modulator of Disease Progression in Familial Pulmonary Arterial Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12729

Pulmonary Arterial Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12729

21 January 2018

Identifiers

DOI

10.1111/RESP.12729

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26809239%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

1 reference